Rating History for Can-Fite BioPharma (CANF) by D. Boral Capital

More Stocks Rated by D. Boral Capital | Latest Ratings for CANF
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/13/2026 Jason Kolbert Upgrade Buy
(Hold)		 7.00
(N/A)		 3.39
(2.98)		 -12.09% Details